Drugs

, Volume 47, Issue 1, pp 1–11 | Cite as

Over-the-Counter Histamine H2-Receptor Antagonists

How will they Affect the Treatment of Acid-Related Diseases?
  • Stephen Holt
Leading Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen M, Schou JS. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status. Pharmacology and Toxicology 69: 253–258, 1991aPubMedGoogle Scholar
  2. Andersen M, Schou JS. Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over the counter sale. Ugeskrift for Laeger 20 (153): 1410–1413, 1991bGoogle Scholar
  3. Andersen M, Schou JS. Safety implications of the over-the-counter availability of H2-antagonists. Drug Safety 8: 179–185, 1993PubMedCrossRefGoogle Scholar
  4. Belloc J, Malats N, Porta M, Gallen M. From first symptom to treatment onset: factors influencing patients health seeking behaviour and health care system delay in digestive tract cancer. Proceedings of II United European Gastroenterology Week, Barcelona, July 19–24, p. A132, 1993Google Scholar
  5. Blum AL, Chalmers TC, Deutsch F. The Lugano statements on controlled clinical trials. Journal of International Medical Research 15: 2–22, 1987PubMedGoogle Scholar
  6. Blum AL, Duroux P, Bauerfeind P. Clinical evaluation of antisecretory agents. In Garner & Whittle (Eds) Advances in drug therapy of gastrointestinal ulceration, pp. 75–87, John Wiley & Sons, New York, 1989Google Scholar
  7. Brown D, Vasudeva R, Colliver J, Holt S. Relationship between symptoms and erosive esophagitis, before and after healing?. American Journal of Gastroenterology 84 (9): 1141, 1989Google Scholar
  8. Colin-Jones DG, Bloom B, Bodemar G. Management of dyspepsia: report of a working group. Lancet 1: 576–9, 1988Google Scholar
  9. Drea EJ. Transition of products from prescription to over the counter: the H2 antagonists. Journal of Pharmacy Practice 5 (1): 22–30, 1992CrossRefGoogle Scholar
  10. Freston JW. On-demand treatment for duodenal ulcers: has its time come?. American Journal of Gastroenterology 85 (3): 241–242, 1990PubMedGoogle Scholar
  11. Gear MW, Barnes RJ. Endoscopic studies of dyspepsia in general practice. British Medical Journal 280: 1136–1137, 1980PubMedCrossRefGoogle Scholar
  12. Heading RC. Chairman’s summary: a round table on dyspepsia. Scandinavian Journal of Gastroenterology 28 (Suppl. 195): 65–66, 1993CrossRefGoogle Scholar
  13. Heatley RV, Rathbone BJ. Dyspepsia: a dilemma for doctors. Lancet 2: 779–782, 1987PubMedCrossRefGoogle Scholar
  14. Holt S. Alcohol and H2-receptor antagonists: over the counter, under the table?. American Journal of Gastroenterology 85: 516–517, 1990aPubMedGoogle Scholar
  15. Holt S. Observations on the relationship between nonulcer dyspepsia and gastric motor function. Gastroenterology Journal Club 2 (3): 9–12, 1990bGoogle Scholar
  16. Holt S. Proton-pump inhibition for acid-related disease. Southern Medical Journal 84: 1078–1087, 1991PubMedCrossRefGoogle Scholar
  17. Holt S, Howden CW. Omeprazole: overview and opinion. Digestive Diseases and Sciences 36 (4): 385–393, 1990CrossRefGoogle Scholar
  18. Holt S, Saleeby G. Gastric mucosal injury induced by anti-inflammatory drugs (NSAIDs). Southern Medical Journal 84 (3): 355–360, 1990CrossRefGoogle Scholar
  19. Holt S, Smith M, Guram M, Skinner HA. Computer assessment of lifestyle in a gastroenterology clinic. Digestive Diseases and Sciences 37 (7): 993–996, 1992PubMedCrossRefGoogle Scholar
  20. Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs 45: 918–930, 1993PubMedCrossRefGoogle Scholar
  21. Howden CW, Holt S. Acid suppression as treatment for NSAlD-related peptic ulcers. American Journal of Gastroenterology 86: 1720–1722, 1991PubMedGoogle Scholar
  22. Inoue M, Sekiguchi T, Harasawa S, Miwa T, Miyoshi A. Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride. Scandinavian Journal of Gastroenterology 28 (Suppl. 195): 36–39, 1993CrossRefGoogle Scholar
  23. Holt S, Irshad M, Howden CW, Maincro M. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal bleeding. Digestive Diseases and Sciences 38: 1619–1623, 1993PubMedCrossRefGoogle Scholar
  24. Kristensen K. Denmark: H2 antagonists over the counter. Lancet 1: 418, 1992CrossRefGoogle Scholar
  25. Langman MJS. Antisecretory treatment and predisposition to cancer. In Garner & Whittle (Eds) Advances in drug therapy of gastrointestinal ulceration, pp. 67–73, John Wiley & Sons, New York, 1989Google Scholar
  26. Malfertheiner P, Megraud F, Pajares J. European Helicobacter pylori study group: the why, when and how to treat Helicobacter pylori in gastroduodenal disease. Proceedings of II United European Gastroenterology Week, July 19–24, Barcelona, p. 66, 1993Google Scholar
  27. Oster G, Huse DM, Delea TE, Colditz GA, Richter JM. The risks and benefits of an Rx-to-OTC switch: the case of over-the-counter H2-blockers. Medical Care 28 (9): 834–852, 1990PubMedCrossRefGoogle Scholar
  28. Petersen H. Over the counter sales of histamine-2 receptor antagonists. Scandinavian Journal of Gastroenterology 155 (Suppl.): 20–22, 1988CrossRefGoogle Scholar
  29. Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP. Changing pattern of gastric cancer in Oxfordshire. Gut 33: 1312–1317, 1992PubMedCrossRefGoogle Scholar
  30. Saleeby G, Howden CW, Holt S. Over the counter (OTC) non-steroidal anti-inflammatory drug (NSAID) use may be an important determinant of complicated peptic ulcer disease (CPUD). American Journal of Gastroenterology 86: 1375, 1991Google Scholar
  31. Schiller LR, Fordtran JS. Ulcer complications during short-term therapy of duodenal ulcer with active agents and placebo. Gastroenterology 90: 478–481, 1986PubMedGoogle Scholar
  32. Sue-Ling HM, Martin I, Griffith J, Ward DC, Quirke P, et al. Early gastric cancer: 46 cases treated in one surgical department. Gut 33: 1318–1322, 1992PubMedCrossRefGoogle Scholar
  33. Talley NJ. Drug treatment of functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (Suppl. 182): 47–60, 1991CrossRefGoogle Scholar
  34. Thorat VK, Misra SP, Anand BS. Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial. American Journal of Gastroenterology 85 (3): 243–248, 1990PubMedGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Stephen Holt
    • 1
    • 2
    • 3
  1. 1.Department of MedicineSeton Hall UniversityUSA
  2. 2.Department of BioengineeringNew Jersey Institute of TechnologyRoselandUSA
  3. 3.Long Island College HospitalBrooklynUSA

Personalised recommendations